Name: Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction - Modification of Dispensing Restrictions for Buprenorphine (Us Departmen (en Inglés)
Price: 106.81 PEN
Availability: InStock
Author: The Law Library
ISBN: 9781729718483

portada Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction - Modification of Dispensing Restrictions for Buprenorphine (Us Departmen (en Inglés)

Formato

Libro Físico

Autor

The Law Library

Editorial

Createspace Independent Publishing Platform

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

25.4 x 17.8 x 0.2 cm

Peso

0.07 kg.

ISBN13

9781729718483

Categorías

Teoría del derecho

Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction - Modification of Dispensing Restrictions for Buprenorphine (Us Departmen (en Inglés)

The Law Library (Autor) · Createspace Independent Publishing Platform · Tapa Blanda

Libro Físico

S/ 106,81

S/ 213,62

Ahorras: S/ 106,81

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 29 de Julio y el Miércoles 07 de Agosto.

Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.

Reseña del libro "Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction - Modification of Dispensing Restrictions for Buprenorphine (Us Departmen (en Inglés)"

Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction - Modification of Dispensing Restrictions for Buprenorphine (US Department of Health and Human Services Regulation) (HHS) (2018 Edition) The Law Library presents the complete text of the Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction - Modification of Dispensing Restrictions for Buprenorphine (US Department of Health and Human Services Regulation) (HHS) (2018 Edition). Updated as of May 29, 2018 This final rule amends the federal opioid treatment program regulations by modifying the dispensing requirements for buprenorphine and buprenorphine combination products approved by the Food and Drug Administration (FDA) for opioid dependence and used in federally certified and registered opioid treatment programs. In particular, this rule would allow opioid treatment programs more flexibility in dispensing take-home supplies of buprenorphine-removing restrictions on the time a patient needs to be in treatment in order to receive take-home supplies-after the assessment and documentation of a patient's responsibility and stability to receive opioid addiction treatment medication. Opioid treatment programs that use these products in the treatment of opioid dependence will continue to adhere to all other federal treatment standards established for methadone. This book contains: - The complete text of the Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction - Modification of Dispensing Restrictions for Buprenorphine (US Department of Health and Human Services Regulation) (HHS) (2018 Edition) - A table of contents with the page number of each section